| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $2.5M | +13.7% |
| SG&A Expense | $6.8M | — |
| Operating Income | -$5.9M | -259.9% |
| Pre-tax Income | -$16.2M | -2818.1% |
| Income Tax | $0 | -100.0% |
| Net Income | -$15.4M | -7634.3% |
| EPS (Basic) | -$1.46 | +73.3% |
| EPS (Diluted) | -$1.46 | +73.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.9M | +2172.7% |
| Current Assets | $62.9M | — |
| Total Assets | $63.9M | -59.3% |
| Current Liabilities | $38.5M | +2189.7% |
| Total Liabilities | $39.2M | +453.1% |
| Stockholders' Equity | $24.7M | +511.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.3M | -1608.1% |
| Capital Expenditures | $30K | +325.3% |
| Investing Cash Flow | -$30K | -325.3% |
| Financing Cash Flow | $11.2M | — |
| Free Cash Flow | -$8.4M | -1589.6% |